申请人:McConnel Darryl
公开号:US20050261350A1
公开(公告)日:2005-11-24
The invention relates to pyrrolobenzimidazolone compounds of formula (I),
wherein A, T and R
1
to R
3
are defined as in claim
1,
which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation and the use thereof for preparing a pharmaceutical composition.
本发明涉及式(I)的吡咯苯并咪唑酮化合物,其中A、T和R1至R3如权利要求1所定义,适用于治疗由过度或异常细胞增殖所特征的疾病,并用于制备制药组合物。